Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Hemab Therapeutics secured $301.5 million in its IPO, pricing at the top of its range. This signals strong investor confidence in biotech, with potential crypto impacts.